Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
about
Bacteria and cancer: cause, coincidence or cure? A reviewInterleukin 12 deficiency associated with recurrent infectionsA natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunityBiology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.Induction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic CellsSevere infectious diseases of childhood as monogenic inborn errors of immunityMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityBacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseasesHost immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosisStriking the Right Balance Determines TB or Not TBIL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation databaseComplex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardSalmonella as a model for non-cognate Th1 cell stimulationGenetics of susceptibility to human infectious diseaseMycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophagesReview of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasisResidual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cellsT cell-mediated host immune defenses in the lungSTAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferationEarly interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cellsGenetic susceptibility to tuberculosis.Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens.A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.Microbial Disease Spectrum Linked to a Novel IL-12Rβ1 N-Terminal Signal Peptide Stop-Gain Homozygous Mutation with Paradoxical Receptor Cell-Surface ExpressionAdult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantOptimized expression and specific activity of IL-12 by directed molecular evolution.Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsSpecificity of signaling by hematopoietic cytokine receptors: instructive versus permissive effects.Dissecting interferon-induced transcriptional programs in human peripheral blood cells.Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonellaMolecular diagnosis of herpes simplex virus infections in the central nervous systemInheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man.Measles: immunosuppression, interleukin-12, and complement receptors.Understanding the genetic basis of susceptibility to mycobacterial infection.Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.
P2860
Q21245476-A5C55CE8-36C7-4E55-A5C6-5ACB1F0FBA28Q22004017-29A149EF-002F-4565-ACC1-F1837989D791Q24673016-0DEC8193-19BD-4824-B7C7-D742D2480E11Q24796992-C8F8885A-78EB-4838-8312-FDCD5B0B664DQ24806655-F68DEDFD-DCD7-43BF-822C-2ADB9D81D2A5Q26764866-6874676D-312D-4AEF-AE99-1A7EC3B093A5Q26775891-5F8E4C9D-4F64-4620-B905-19FDE9249077Q26862947-7C3552F5-1251-4CA1-B6A0-0956DA6775FBQ26863260-B51A742C-51DA-42F0-854F-7DAEFEAAB1C5Q26863391-952F1A01-4C5C-4853-AE33-8F76D98EDAC2Q27001010-242B50A1-5B6A-467A-81D8-4D2EE57273A7Q27022796-D98EF90C-E953-44A7-B5CB-790D47314C6BQ27694492-12B33498-7D9F-4D94-B967-69E5A0EDC6C4Q28082931-E929F55C-AA7B-45F2-B0BA-D096A32E68F6Q28208872-29261465-3E16-44BF-AB74-B7C4521B5377Q28279932-F6B45ED2-E962-4778-A9C0-9772B16971CAQ28280687-36E37CF9-A186-47EF-AE9D-3C15127789F5Q28344650-01385894-2833-4DC1-BED3-689A639AFDADQ28395374-96A7CF88-F3F3-4C59-87DC-97B77AAC70FAQ28590165-E3EBCCC6-A70B-4612-95D9-C60A02D66E47Q28748686-5B89FB86-79D4-4841-8D14-76175573929AQ30332232-0337E58C-142B-4789-9B2A-4B33310A663FQ30400261-FEF08B54-7B07-4BDA-A09A-66723EBF9FB7Q30492620-105FC1CD-81A0-42E3-81B9-B99794C88D30Q30845113-ED7AC024-AFE0-4255-8605-B8314899AA0AQ30853592-A64498F0-13F3-40D9-A3CF-DF686AED0E4CQ33185720-C778C301-E26B-4D99-B8EE-4077387FE8D7Q33222437-D3D4E492-DB5E-4C14-B800-1864E1FA03FCQ33255341-D27D78EC-04B4-4219-AC99-3CF02A32DCF9Q33265416-E2E35527-5999-4D9F-A04A-3F32EE094529Q33459148-A740C922-BAB3-41FF-B7D3-2D7719C9A4F4Q33540009-86C063C5-93F5-4728-AF0F-0FB806CCFA20Q33546362-72570FD8-0D4A-415D-B4C5-60168EB60F45Q33554688-B982DA06-52F0-44DE-AE20-962EBD12792DQ33588166-591523B1-3209-4FF6-A582-A53978DCE0D4Q33655137-BB3C11CC-B3B4-45C0-B08A-41E22BA690E7Q33669243-677CFBD3-CAFD-4783-AD11-4793313C5F78Q33683348-B95A952E-4793-4962-A470-875D1B53BD10Q33694076-3C8860A4-4B38-4D09-8B4F-3FDD98F1F73EQ33730164-D4AAB515-2933-4A45-99B7-D59060382911
P2860
Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@ast
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en-gb
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@nl
type
label
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@ast
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en-gb
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@nl
prefLabel
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@ast
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en-gb
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@nl
P2093
P921
P1433
P1476
Severe mycobacterial and Salmo ...... 12 receptor-deficient patients
@en
P2093
D G Elferink
I A Haagen
J M Draaisma
J T van Dissel
P J van Breda Vriesman
P304
P356
10.1126/SCIENCE.280.5368.1435
P407
P577
1998-05-01T00:00:00Z